Key facts
- This page summarizes John C. Thomas's Form 4 filing for Dogwood Therapeutics, Inc. (DWTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2026, 13:18.
John C. Thomas - 16 Jun 2026 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)
- Reporting relationship
- Director
- Issuer ticker
- DWTX
- Reported as of
- 16 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2026, 13:18:46 UTC
- Prior SEC filing
- 01 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Greg Duncan, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John C. Thomas filed Form 4 for Dogwood Therapeutics, Inc. (DWTX) on 17 Jun 2026.
Change
- Previous filing in this sequence was filed on 01 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001424620
Primary reporting owner
Thomas John C
- Relationship
- Director
- Address
- C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA
- Signature
- /s/ Greg Duncan, Attorney-in-Fact
- Signature date
- 17 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DWTX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +16,800
- Change %
- Price
- $0.000000*
- Shares after
- 16,800
- Date
- 16 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,800
- Exercise price
- $1.50
* marks a reported price that did not pass the local price check.